Skip to main content

Month: January 2024

CorMedix Inc. Announces Commercial and Reimbursement Updates

BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced updates related to its business and anticipated launch of DefenCath®. Recent Updates:On January 25, 2024 the Center for Medicare & Medicaid Services (CMS) notified CorMedix that the agency has determined DefenCath will be eligible for reimbursement in accordance with the ESRD PPS. As such, CorMedix is entitled to submit an application for a Transitional Drug Add-On Payment (TDAPA) which currently allows for five years of additional payment reimbursement to outpatient providers. CorMedix submitted its TDAPA application on January 26th after receiving the...

Continue reading

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform

LAKEWOOD, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance” or the “Company”), today announced that it has added the RELI Exchange Client Referral Portal (CRP) into its proprietary InsurTech platform, RELI Exchange. Ezra Beyman, CEO of Reliance, stated, “Since its inception, RELI Exchange has been consistently evolving to offer better functionality and provide greater benefits to our existing and prospective agency partners. We recently launched the proprietary RELI Exchange CRP, designed to help agency partners establish and strengthen connections with a range of professional service providers, including but not limited to, real estate agents, car dealerships, and mortgage brokers. These professionals frequently interact with clients in need of insurance products. Using this...

Continue reading

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and ApplicationSI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and ApplicationSANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite® Implant System (Granite) in a smaller (9.5 mm) diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the S1 trajectory. When placed across the SI joint, the Granite implant provides sacroiliac fusion and sacropelvic...

Continue reading

Seanergy Maritime Achieves Key Partnership with European Union Funding and Major Industry Stakeholders Under SAFeCRAFT to Revolutionize Maritime Propulsion for Existing Vessels

ATHENS, Greece, Jan. 30, 2024 (GLOBE NEWSWIRE) — Seanergy Maritime Holdings Corp. (the “Company” or “Seanergy”) (NASDAQ: SHIP), through its wholly-owned subsidiary Seanergy Shipmanagement Corp., is the first Greek-based shipping company to accomplish a strategic partnership in the European Union Funded SAFeCRAFT Project Consortium (“Safecraft”), a breakthrough initiative concerning the utilization of alternative fuels. Safecraft aims to demonstrate the safety and viability of Sustainable Alternative Fuels (SAFs) in seaborne transportation, accelerating the adoption of SAFs technologies. Seanergy will provide one of its existing, conventionally fueled Capesize vessels as the demonstrating vessel under Safecraft which will be retrofitted to utilize hydrogen (H2) as the main energy source for electric power...

Continue reading

Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces Accelerates

Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint sweat-based drug testing Construction and manufacturing firms replace traditional urine and oral fluid drug tests with more hygienic and dignified Intelligent Fingerprinting Drug Screening System – disrupting workplace testing market NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today reported on the key operational benefits that customers are experiencing following deployment of the Intelligent Fingerprinting Drug Screening System to support workplace drug testing. Customers across critical sectors such as construction, manufacturing...

Continue reading

KYN Capital Group Announces Koinfold 2.0 is Now Available on the iOS Store

RANCHO CORDOVA, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — KYN Capital Group (OTC:KYNC) is pleased to announce a new upgraded version for Koinfold 2.0. has been approved and released on the iOS store. Download Koinfold 2.0 on iOS and Google Play Store Today Check out the New Features:“Learn to Earn” gives the user $10,000 in play cryptocurrency to test the market, no risk. It’s the safest and easiest way to learn. cryptocurrency swap features within the app. 24/7 cryptocurrency news from over 50 editorials. Mine crypto through Cudominer email verification for securityNew marketing initiatives include growing all our social media Platforms:YouTube channel Instagram TikTok social platform Twitter X Discord channel for users is replacing the Messaging feature that has been discontinued in both versions of...

Continue reading

QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company

This integration allows QHSLab access to more than 160,000 providers that are the exact match for target providers. WEST PALM BEACH, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) — QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce the seamless integration of its digital medicine assessments with one of the nation’s top Electronic Health Record (EHR) Company. This update demonstrates promising growth for QHSLab in its mission to revolutionize provider workflow and elevate the quality of patient care. The more than 160,000 providers utilizing this EHR system will now have direct access to QHSLab’s comprehensive suite of digital medicine assessments and monitoring...

Continue reading

GCM Grosvenor to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Conference Call on February 13, 2024

CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the fourth quarter and full year 2023 on Tuesday, February 13, 2024. Management will host a webcast and conference call on Tuesday, February 13, 2024 at 10:00 a.m. ET to discuss the results and provide a business update. The conference call will be available via public webcast through the Public Shareholders section of GCM Grosvenor’s website at www.gcmgrosvenor.com/public-shareholders and a replay will be available on the website soon after the call’s completion for at least seven (7) days. To register for the call, visit www.gcmgrosvenor.com/public-shareholders. About GCM Grosvenor GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management...

Continue reading

Western Uranium & Vanadium Bolsters Mining Team to Scale-Up Uranium Production

Toronto, Ontario and Nucla, Colorado, Jan. 30, 2024 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the ”Company”) is excited to announce the elevation of Michael Rutter to the position of Chief Operating Officer and the addition of Bruce Norquist to the team as General Manager of Mining Operations. Michael Rutter, who joined the company as Vice President of Operations in 2016, has been promoted to Chief Operating Officer. During his 22 years in the mining business, Mr.Rutter has gained extensive experience in conventional uranium and vanadium mining and mineral processing. This includes roles as Maintenance and Operations Superintendent for Energy Fuel Inc.’s production in Utah, Colorado, and Arizona. Previously, Mr. Rutter oversaw maintenance, planning, and development for Lisbon...

Continue reading

Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies

CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced its recognition by Forbes as one of America’s Most Successful Small-Cap Companies. Forbes used data from FactSet to compile its annual list of America’s Most Successful Small-Cap Companies. They screened nearly 1,000 companies with a market value between $300 million and $2 billion to find 389 companies that also had positive sales growth over the past 12 months and a share price of at least five dollars.  “We are extremely appreciative to be recognized as one of America’s Most Successful Small-Cap Companies,” said Marc Baumann, Chairman and Chief Executive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.